Returned veterinary medicinal products shall be handled according to a written, risk-based process taking into account the nature of the veterinary medicinal product concerned, any special storage conditions it requires and the time elapsed since it was supplied. Returns shall be conducted in accordance with national law and contractual arrangements between the parties.
Veterinary medicinal products which have left the care of the persons referred to in Article 1(2) shall only be returned to saleable stock if all of the following conditions are met:
the veterinary medicinal products are in their unopened and undamaged secondary packaging and are in good condition;
the veterinary medicinal products have not expired and have not been recalled;
the veterinary medicinal products returned from a customer not holding a wholesale distribution authorisation or from pharmacies or persons authorised to supply veterinary medicinal products to the public in accordance with national law of the Member State concerned have been returned within a defined acceptable time limit determined by using quality risk management principles;
the veterinary medicinal products have not been returned by the animal owner to the pharmacy or to other persons authorised to supply veterinary medicinal products to the public in accordance with national law of the Member State concerned, unless such return is permitted under national law of that Member State;
it has been demonstrated by the customer that the veterinary medicinal products have been transported, stored and handled in compliance with their specific storage requirements;
the veterinary medicinal products have been examined and assessed by a sufficiently trained and competent person authorised to do so;
the persons referred to in Article 1(2) have reasonable evidence that the veterinary medicinal product was supplied to the customer returning the veterinary medicinal product, as evidenced by copies of the original delivery note or by referencing invoice numbers, batch numbers, expiry date etc., as required by national law, and that there is no reason to believe that the veterinary medicinal product has been falsified.
For veterinary medicinal products requiring specific temperature storage conditions such as low temperature, returns to saleable stock shall only be made if there is documented evidence that the product has been stored under the authorised storage conditions throughout the periods in points (a) to (f). If any deviation has occurred, a risk assessment shall be performed, which shall demonstrate the integrity of the veterinary medicinal product. The evidence shall cover all the following steps:
delivery to the customer;
examination of the veterinary medicinal product;
opening of the transport packaging;
return of the veterinary medicinal product to the packaging;
collection and return to the persons referred to in Article 1(2);
return to the wholesale distribution site refrigerator.
Products returned to saleable stock shall be placed so that the ‘first expiry, first out’ system operates effectively.
Stolen veterinary medicinal products that have been recovered shall not be returned to saleable stock nor sold to customers.